Null-Pointer Dereference Vulnerability in VMware ESXi
CVE-2022-31681

6.5MEDIUM

Key Information:

Vendor

Vmware
Status
Vmware Esxi
Vendor
CVE Published:
7 October 2022

What is CVE-2022-31681?

VMware ESXi contains a null-pointer dereference vulnerability that can be exploited by a malicious actor with sufficient privileges in the VMX process. This flaw can lead to a denial of service condition on the host, disrupting the availability of services. Proper security measures should be implemented to mitigate the risks associated with this vulnerability. For further details, refer to VMware's official security advisory.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

VMware ESXi VMware ESXi (7.0 prior to ESXi70U3sf-20036586, 6.7 prior to ESXi670-202210101-SG & 6.5 prior to ESXi650-202210101-SG)

References

https://www.vmware.com/security/advisories/VMSA-2022-0025...

CVSS V3.1

Score:
6.5
Severity:
MEDIUM
Confidentiality:
None
Integrity:
None
Availability:
None
Attack Vector:
Local
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.